Compounds suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation, pharmaceutical preparations containing compounds of this type and use as drugs. Claim 1: A compound of the general formula (1) characterized in that: R¹ indicates C₁₋₄ alkyl；R² indicates hydrogen or C₁₋₄-alkyl；R³ indicates hydrogen or C₁₋₄ alkyl；n indicates 0 or 1； ring A is 5-6 membered phenyl or heteroaryl； each R⁴ is independently selected from one of halogen, C₁₋₄ alkoxy,C83218331y-cn No.； P means 0, 1 or 2； ring B is 5 member heteromorphic； each r83099 is independent r7495；； 1 or a group, optionally one or more r7495；； 1 and / or r7580801； 1identical or different selected from C₁₋₆-alkyl,C₂₋₆ alkenyl,1. C 83228331 asphalt；haloalkyl C₁₋₆,cycloalkyl C₃₋₆,cycloalkenyl C₄₋₆,1. Phenyl, isomer of 5-6 members and isomer of 3-7 members； each r7495；]-7580； - 7580； - 1,Halogen, - CN, - C (o) r7580；； 1-C (O) OR-C (O) NR R-S (O) R-S (O) NR R-NHC (O) Rᶜ¹ and -N (C₁₋₄-alkyl) C (O) Rᶜ¹；Each r7580801；； 1 represents hydrogen or a group independent of the other r75801, and one or more r7496；； 1 and / or r7497；； 1identical or different selected from C₁₋₆-alkyl,C₂₋₆ alkenyl,1. C 83228331 asphalt；haloalkyl C₁₋₆,cycloalkyl C₃₋₆,cycloalkenyl C₄₋₆,1. Phenyl, isomer of 5-6 members and isomer of 3-7 members； each r7496；； 1 is independent of - or7497；,Nr.7497；]Halogen, - CN, - C (o) r7497；； 1-C (O) OR-C (O) NR R-S (O) R-S (O) NR R-NHC (O) R y -N (alquilo C) C (O) RR7497；]identical or different selected from C₁₋₆-alkyl,C₂₋₆ alkenyl,1. C 83228331 asphalt；haloalkyl C₁₋₆,cycloalkyl C₃₋₆,cycloalkenyl C₄₋₆,1. Phenyl, isomers of 5-6 members and isomers of 3-7 members； each r758484； 1. Selected independently without interfering with - or75011；-7501； - 750101； - 1,Halogen, - CN, - C (o) r7501；； 1,-C (O) OR-C (O) NR R-S (O) R-S (O) NR R-NHC (O) Rᵍ¹ and -N (C₁₋₄-alkyl) C (O) Rᵍ¹；each Rᵍ¹ independently of one another indicates hydrogen or C₁₋₆ alkyl；Q is 0, 1 or 2； ring C is phenyl or 5-6 non
